Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Workers at Tesla's Gigafactory 2 in Buffalo, New York said the automaker fired dozens of employees after they announced plans to form a union, according to a Bloomberg News report.
Veronica Willis, investment strategy analyst with Wells Fargo Investment Institute, joined Cheddar News to discuss Wednesday's trading session following better-than-expected retail sales and what's on tap for the markets this year.